Last reviewed · How we verify
ethinyl estradiol/etonogestrel vaginal ring — Competitive Intelligence Brief
marketed
Combined hormonal contraceptive
Estrogen receptor and progesterone receptor
Contraception / Reproductive Health
Small molecule
Live · refreshed every 30 min
Target snapshot
ethinyl estradiol/etonogestrel vaginal ring (ethinyl estradiol/etonogestrel vaginal ring) — University of Pittsburgh. Ethinyl estradiol and etonogestrel work together as a combined hormonal contraceptive that suppresses ovulation and alters cervical mucus to prevent pregnancy.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| ethinyl estradiol/etonogestrel vaginal ring TARGET | ethinyl estradiol/etonogestrel vaginal ring | University of Pittsburgh | marketed | Combined hormonal contraceptive | Estrogen receptor and progesterone receptor | |
| Ethinyl Estradiol / Norgestimate Oral Tablet | Ethinyl Estradiol / Norgestimate Oral Tablet | University of Colorado, Denver | marketed | Oral contraceptive (combined estrogen-progestin) | Estrogen receptor and progesterone receptor | |
| ethinyl estradiol/norelgestromin transdermal contraceptive | ethinyl estradiol/norelgestromin transdermal contraceptive | University of Pittsburgh | marketed | Hormonal contraceptive | Estrogen receptor and progesterone receptor | |
| Estradiol valerate / dienogest | Estradiol valerate / dienogest | Helsinki University Central Hospital | marketed | Oral contraceptive (combined estrogen-progestin) | Estrogen receptor and progesterone receptor | |
| ETHINYL ESTRADIOL AND LEVOGESTREL | ETHINYL ESTRADIOL AND LEVOGESTREL | FHI 360 | marketed | Combined oral contraceptive | Estrogen receptor and progesterone receptor | |
| OCR | OCR | Hoffmann-La Roche | marketed | Combined oral contraceptive | Estrogen receptor and progesterone receptor | |
| placebo + ethinylestradiol/levonorgestrel | placebo + ethinylestradiol/levonorgestrel | HRA Pharma | marketed | Combined oral contraceptive | Estrogen receptor and progesterone receptor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Combined hormonal contraceptive class)
- Andrea Roe, MD, MPH · 1 drug in this class
- Organon and Co · 1 drug in this class
- University of Pittsburgh · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- ethinyl estradiol/etonogestrel vaginal ring CI watch — RSS
- ethinyl estradiol/etonogestrel vaginal ring CI watch — Atom
- ethinyl estradiol/etonogestrel vaginal ring CI watch — JSON
- ethinyl estradiol/etonogestrel vaginal ring alone — RSS
- Whole Combined hormonal contraceptive class — RSS
Cite this brief
Drug Landscape (2026). ethinyl estradiol/etonogestrel vaginal ring — Competitive Intelligence Brief. https://druglandscape.com/ci/ethinyl-estradiol-etonogestrel-vaginal-ring. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab